Wuhan Binhui Biopharmaceutical Co., Ltd.
PrivateLast Round
Private Equity
Dec 1, 2023
Est. Valuation
$450M
Total Funding Raised
$159.8M
Company Overview
Wuhan Binhui Biopharmaceutical Co., Ltd. is a biotechnology company that specializes in the research, development, and production of oncolytic virus drugs and other macromolecular therapeutic products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan Binhui Biopharmaceutical Co., Ltd. Comparables
Compare Wuhan Binhui Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou ConVerd Co., Ltd. | 89% | |
| Beijing WellGene Biotech Co., Ltd. | 87% | |
| ImmVira | 85% | |
Wuhan Binhui Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Dec 1, 2023 | ||||
| Series B Extension | Apr 19, 2022 | ||||
| Series B | Feb 25, 2021 | ||||
| Series A | Aug 4, 2018 |
Wuhan Binhui Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Series B |
| Haoyue Capital | Series B |
| Hubei High-tech Industrial Investment Group | Series B Extension |
| Qianhai Ark Asset Management | Series B |
| Share Capital | Series B |
| Ming Capital | Series B Extension |
| Vertex Ventures China | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2023
Raised $3M in a private equity round.
- Apr 19, 2022
$47M round led by Yangtze River Pharmaceutical Group
Wuhan Binhui Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wuhan Binhui Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.